Letters to the Editor

Vecabrutinib inhibits B-cell receptor signal transduction in chronic lymphocytic leukemia cell types with wild-type or mutant Bruton’s tyrosine kinase

Department of Experimental Therapeutics
Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston
Sunesis Pharmaceuticals, Inc., South San Francisco
Sunesis Pharmaceuticals, Inc., South San Francisco
Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston
Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston
Department of Experimental Therapeutics; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston
Haematologica Early view Sep 9, 2021 https://doi.org/10.3324/haematol.2021.279158